Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Reuters Rating of PTSC is back up to "Outperform"

Not sure when this happened but a few weeks ago the rating was "neutral". Outperform is Reuters highest rating defined as follows -

"Shares of PTSC are rated OUTPERFORM. Outperform-rated stocks score in the top 30% of all stocks Reuters rates and are expected to offer higher returns than the market as a whole"

Share
New Message
Please login to post a reply